Clinical Trial Update: High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating high-dose interferon and pegylated interferon as induction therapy in difficult-to-treat genotype 1 hepatitis C patients; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• high-dose interferon (interferon)

Snippet

Sponsor: Foundation for Liver Research | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED